GRM5 and movement disorder: The observed neurologic manifestations were behavior or personality/mood changes (91%), altered cognition (91%), sleep disturbances (64%), seizures (55%), decreased level of consciousness (55%), movement disorders (45%).[4] However, the effects of mGluR5 antibodies are not clear.